|
Press Releases |
|
|
|
Wednesday, April 7, 2021 |
|
Agilex Biolabs acquires leading biolab TetraQ for APAC Expansion Plans |
Agilex Biolabs, Australia's largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, today announced the purchase of leading biolab TetraQ, based out of the University of Queensland. more info >> |
|
Monday, March 22, 2021 |
|
Agilex Biolabs Showcases Advanced Immunoassay and Immunobiology Services at Bio-Europe Spring 2021 |
Agilex Biolabs, Australia's largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, announced it will showcase its world-class immunoassay and immunobiology services for regulated bioanalysis at Bio-Europe 2021. more info >> |
|
Friday, October 30, 2020 |
|
Agilex Biolabs Client Shasqi Announces Click Chemistry Breakthrough with First-Ever Human Application in Launch of Clinical Program |
Agilex Biolabs, Australia's most advanced FDA-inspected specialist bioanalytical laboratory for clinical trials, congratulates client company Shasqi on the announcement of the first-ever application of click chemistry in humans, with the launch of the Company's lead clinical candidate, SQ3370. Shasqi is the first Y Combinator-backed biotech company to reach clinical development. more info >> |
|
Tuesday, October 27, 2020 |
|
Endpoints News Presents "Why Australia and Agilex Biolabs for your Next Clinical Trial" for Bio Europe 2020 |
Agilex Biolabs, Australia's most advanced FDA-inspected specialist bioanalytical laboratory for clinical trials, has partnered with Endpoints News to produce an exceptional step-by-step webinar on how to run your trial in Australia, and why Agilex Biolabs is the leading biolabs partner. Watch here (no charge) https://tinyurl.com/yyzf6o44 more info >> |
|
Wednesday, September 23, 2020 |
|
Agilex Biolabs Develops World's Most Accurate Cannabinoid Assay |
Award-winning Agilex Biolabs, the Asia-Pacific region's leading bioanalytical laboratory for clinical trials, based in Australia, has developed the world's most accurate cannabinoid assay. more info >> |
|
Wednesday, July 22, 2020 |
|
Agilex Biolabs and Endpoints News Present 'How to Move Trials to Australia' Webinar |
Agilex Biolabs, Australia's largest specialist bioanalytical laboratory for clinical trials, and Endpoints News launched a new webinar "How Easy is it to Move Your Trials to Australia" at BIO Taiwan 2020. more info >> |
|
Thursday, June 11, 2020 |
|
Agilex Biolabs Encourages Biotechs to Move Delayed Trials to Australia at BIO Digital 2020 |
Agilex Biolabs, Australia's largest specialist bioanalytical laboratory for clinical trials, encouraged biotechs to consider Australia for their clinical trials during a presentation at BIO Digital 2020. more info >> |
|
Wednesday, May 20, 2020 |
|
Agilex Biolabs Presents the Australian Advantage, including the World's Largest Rebate on Clinical Trial Spend, at BIO Korea 2020 |
Agilex Biolabs, Australia's largest specialist bioanalytical laboratory for biotech clinical trials, is presenting the Australian Advantage including the world's most attractive rebate on clinical trials costs, at BIO Korea 2020. more info >> |
|
Thursday, April 2, 2020 |
|
Agilex Biolabs Taps Biopharma Leader Dr Caroline Popper for Board Chair as part of APAC Bioanalytical Services Growth |
Award-winning Australian bioanalytical laboratory Agilex Biolabs announced today it has appointed US-based Dr Caroline Popper, MBBS, MPH as Board Chair as part of its APAC clinical trials bioanalytics growth plans. more info >> |
|
Friday, March 13, 2020 |
|
Agilex Biolabs Announces 30% Labs Expansion and Offers Virtual Lab Tours During COVID-19 Outbreak |
Award-winning Australian bioanalytical laboratory Agilex Biolabs announced today it has expanded its lab facilities by more than 30% to accommodate demand, mainly from US and APAC-based biotech companies. more info >> |
|
|
|
|
|
|
|
|
|
Latest Press Releases |
|
MHI Concludes Positive Impact Finance Agreement
Mar 29, 2024 19:20 JST
|
|
|
Atlas Lithium Secures US$ 30,000,000 Strategic Investment and Offtake Agreement from Mitsui
Mar 29, 2024 18:09 HKT/SGT
|
|
|
Guoquan: Continuously Expanding the Business Scale While Enhancing Profitability
Mar 29, 2024 18:02 HKT/SGT
|
|
|
Legend Holdings Realized Revenue of RMB436 billion in 2023
Mar 29, 2024 16:55 HKT/SGT
|
|
|
Panasonic Energy and Mazda Enter Agreement Towards Supply of Cylindrical Automotive Lithium-ion Batteries
Mar 29, 2024 17:42 JST
|
|
|
Gome Retail Streamlines to Focus on Main Business
Mar 29, 2024 15:07 HKT/SGT
|
|
|
Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical
Mar 29, 2024 15:51 JST
|
|
|
Gome Fin Tech Announced Annual Results of 2023
Mar 29, 2024 14:36 HKT/SGT
|
|
|
Eisai's Brain Health Self-Check Tool "NouKNOW" is Certified as "ME-BYO BRAND" by Kanagawa Prefecture
Mar 29, 2024 15:19 JST
|
|
|
Baguio Green's 2023 Adjusted Net Profit increased by 36.7%
Mar 29, 2024 14:15 HKT/SGT
|
|
|
Eisai: Discovery Research on Dual Orexin Receptor Antagonist Lemborexant Honored with PSJ Award for Drug Research and Development 2024
Mar 29, 2024 14:32 JST
|
|
|
Forward Fashion Announced 2023 Annual Results
Mar 29, 2024 13:29 HKT/SGT
|
|
|
Netjoy records new high gross billing hitting RMB8.137 billion in 2023
Mar 29, 2024 12:27 HKT/SGT
|
|
|
Sino Biopharm (1177.HK) Announces 2023 Annual Results
Mar 29, 2024 11:45 HKT/SGT
|
|
|
Wintermar Offshore (WINS:JK) Reports FY2023 Results
Mar 29, 2024 10:15 HKT/SGT
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|